In Gov. Gavin Newsom’s new interview with Chuck Todd, the CA Governor bemoans the anger he faced after his much-derided COVID-19 lockdown strategy, now saying “I think we would’ve done everything differently” in hindsight and “I think there’s a lot of humility” – before backtracking and passing the blame to others: “we didn’t know what we didn’t know. And it was hardly I; it was we, collectively.”
John Phillips and Dr. Kelly Victory discuss the new wave of history-rewriting and blame-passing from officials who previously championed lockdowns and mandates but are suddenly changing their tune as election season approaches.
Effective virucidal agent against all coronaviruses, including SARS- COV-2.
Effective in case of both pre and post exposure.
Effective for healthy individual (for protection) as well as COVID-19 patient also ( for reduction of viral load and SARS-CoV-2 transmissibility for close contacts/ family members).
Almost no side effect (mucosal irritation, thyroid dysfunction, teeth staining,).
This minimum concentration of PVP-I (0.6%) has least possibility of doing any harm to human body (nasal or oral mucosa). More concentration is being used on eye, ear, mucosa of oral cavity, oropharynx since before.
Single container, double function (PVP-I Oral/Throat spray as well as Nasal spray)
Easy to carry (in pocket, handbag)
Easy to use
No need to have a basin or a facility to gargle or spit
Minimum amount of PVP-I solution is needed (20 ml solution can be used for 20- 30 days for regular user.)
Cheap (to refill)
Minimum Iodine exposure.
Container can be reusable and refillable.
Recommendations
PVP-I Oro Nasal Spray should be used by doctors or other health care workers (HCW), COVID-19 patients as well as common people.
For Doctors or Other Health Care Workers (HCW).
Prior to visit any patient in any facility irrespective of COVID status
Prior to examining the oral cavity, throat or nose of any patient
Prior to any Surgery, specially surgery of Nose, mouth, throat, ear, skull base
Prior to attend COVID-19 patient in a COVID-19 dedicated unit / hospital
Following exposure to confirmed or suspected COVID patient (intentional/accidental)
For Common People
Prior to attend public gathering or working outside home, where there is chance of known or unknown COVID-19 patient/ SARS-CoV-2 exposure.
Before leaving and after returning home and in between 1 or 2 time (after tea/lunch/dinner break).
For COVID-19 patientsAs it has the potentiality to reduce the viral load, it will definitely reduce the viral transmission from patient to healthy person. Again, it may have positive role on treatment, in mortality and morbidity index. To prove this further studies are recommended.
How to use: 2–3 puff in each nostril and 1–3 puff in throat (oral cavity and oropharynx) in 3–4 h interval.
How long? Though it is proved and established that long term (1–2 months) application of this minimum amount of PVP-I is quite safe SPS:refid::bib2|bib3|bib4[2,3,4]. But, I recommend after continuous use of 1–2 week 1 day interval (weekly holiday) should be given.
Conclusion
PPE, mask, hand sanitization or vaccines nothing proved 100% effective for COVID-19 prevention still now. PVP-I oro-nasal spray is an easy tool or way for COVID-19 prevention and reduction of SARS-CoV-2 transmissibility. I recommend here, this oro-nasal spray should be used as an adjunct to PPE, mask or vaccine. Any person, policy maker, local or central government could adopt this safe, cheap, easily available and effective PVP-I Oro-Nasal spray as an additional shield of their COVID-19 protection and thus minimize the COVID burden.
Professor of medicine at Stanford University and co-founder of, ‘Illusion of Consensus,’ Substack Dr. Jay Bhattacharya talks about the Missouri v. Biden case. #freespeech#federalcourt
According to the CDC, all COVID-19 vaccines currently available in the United States are effective at preventing COVID-19. Getting sick with COVID-19 can offer some protection from future illness, sometimes called “natural immunity,” but the level of protection people get from having COVID-19 may vary depending on how mild or severe their illness was, the time since their infection, and their age. Getting a COVID-19 vaccination is also a safer way to build protection than getting sick with COVID-19. COVID-19 vaccination helps protect you by creating an antibody response without you having to experience sickness. Getting vaccinated yourself may also protect people around you, particularly people at increased risk for severe illness from COVID-19.
Getting sick with COVID-19 can cause severe illness or death, and we can’t reliably predict who will have mild or severe illness. If you get sick, you can spread COVID-19 to others. You can also continue to have long-term health issues after COVID-19 infection. According to the CDC all COVID-19 vaccines currently available in the United States are effective at preventing COVID-19. Getting sick with COVID-19 can offer some protection from future illness, sometimes called “natural immunity,” but the level of protection people get from having COVID-19 may vary depending on how mild or severe their illness was, the time since their infection, and their age. The FDA has not authorized or approved ivermectin for use in preventing or treating COVID-19 in humans or animals. Ivermectin is approved for human use to treat infections caused by some parasitic worms and head lice and skin conditions like rosacea. Currently available data do not show ivermectin is effective against COVID-19. Clinical trials assessing ivermectin tablets for the prevention or treatment of COVID-19 in people are ongoing. Taking large doses of ivermectin is dangerous. If your health care provider writes you an ivermectin prescription, fill it through a legitimate source such as a pharmacy, and take it exactly as prescribed. Never use medications intended for animals on yourself or other people. Animal ivermectin products are very different from those approved for humans. Use of animal ivermectin for the prevention or treatment of COVID-19 in humans is dangerous.
In April 2021, increased cases of myocarditis and pericarditis were reported in the United States after mRNA COVID-19 vaccination (Pfizer-BioNTech and Moderna). Data from multiple studies show a rare risk for myocarditis and/or pericarditis following receipt of mRNA COVID-19 vaccines. These rare cases of myocarditis or pericarditis have occurred most frequently in adolescent and young adult males, ages 16 years and older, within 7 days after receiving the second dose of an mRNA COVID-19 vaccine (Pfizer-BioNTech and Moderna). There has not been a similar reporting pattern observed after receipt of the Janssen COVID-19 Vaccine (Johnson & Johnson). CDC continues to recommend COVID-19 vaccination for everyone 6 months of age and older. The Advisory Committee on Immunization Practices (ACIP) and CDC have determined that the benefits (such as prevention of COVID-19 cases and its severe outcomes) outweigh the risks of myocarditis and pericarditis after receipt of mRNA COVID-19 vaccines.
According to the CDC, Atrazine is a widely used chlorotriazine herbicide active against broadleaf and grassy weeds. Related chlorotriazine herbicides include simazine, propazine, and cyanazine, all which act by inhibiting plant photosynthesis. Atrazine is applied pre- and post-emergence to agricultural land for crops such as corn and sorghum. It is also used as a non-selective herbicide. Atrazine was first registered as an herbicide in 1958. More than 70 million pounds have been applied annually in recent years, with about 75% of corn cropland receiving treatment. Atrazine has limited water solubility and is not tightly bound to soil, but is leachable in to ground and surface waters. In regions where atrazine is used, it is one of the more commonly detected pesticides in surface and ground waters (USGS, 2007). In soils, atrazine is slowly degraded to dealkylated products, which have half-lives of several months. Bacteria and plants can metabolize atrazine to hydroxyatrazine. Atrazine does not bioaccumulate. It has little toxicity in birds and moderate toxicity in some fish and aquatic invertebrates. Atrazine may alter the sexual development of frogs at environmental levels (Gammon et al., 2005; Hayes et al., 2002; U.S.EPA, 2003a).
There is a battle going on for our freedoms this week. And very few Americans are even aware of what is at stake.
The order concerns quarantine of citizens by the state government. Like other states, New York already has in place laws regarding quarantine of the citizenry – laws duly passed by the elected state representatives. Those laws were crafted by legislators (whose job it is to do this work) and passed by a majority vote of both Assembly and Senate and signed by the governor. That law not only provides for protecting the public by use of quarantine, but also includes protections for individual rights.
There are problems with the governor’s action.
The executive branch does not have the power to make laws under the constitution. That is reserved to the legislature.
With one state executive branch taking power not given to them constitutionally, it creates a precedent that could be used similarly for other issues to violate the rights of citizens on a host of other issues – not only in New York, but in all the other states as well.
So, what is in this regulation, you ask? It has to do with quarantine of the citizenry…
Dr. Harvey Risch, Professor Emeritus of Epidemiology at Yale School of Public Health, talks about the safety of COVID vaccines and his research paper examining deaths after COVID-19 vaccination.
